Company profile
Minovia Therapeutics
A clinical-stage international biotechnology research company focused on treatment innovation for mitochondrial disease
- Industry
- Biotechnology Research
- Employees
- 23
- Headquarters
- Haifa, Israel
- Founded
- 2012
- LinkedIn followers
- 5,637
- Office locations
- 2
Minovia Therapeutics company summary
Minovia Therapeutics is a company in the Biotechnology Research industry, headquartered in Haifa, Israel, founded in 2012. On LinkedIn the company has around 23 employees and 5,637 followers. The company lists 2 office locations. Its listed specialties include Biotechnology, cell therapy, Rare diseases, Mitochondria, Mitochondrial Diseases.
What technology does Minovia Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Minovia Therapeutics
Minovia is a clinical stage company focused on the development and application of mitochondrial cell therapies for patients suffering mitochondrial dysfunction. Mitochondrial Augmentation Technology (MAT) is a cell therapy platform where an off-the-shelf allogeneic isolated mitochondria are developed as cryopreserved, healthy and functional, energy producing organelles and used to augment various cell types to be used as therapeutics products. The lead product, MNV-201 consists of autologous hematopoietic stem and progenitor cells (HSPCs) augmented ex vivo with healthy mitochondria. MNV-201 is currently in clinical trial for Pearson Syndrome and in Pre-clinical stage for Myelodysplastic Syndrome (MDS) indicating encouraging clinical and pre-clinical proof-of-concept for both primary mitochondrial diseases and age-related bone marrow failures. In Minovia we developed novel mitochondria-based biomarkers that allows us to stratify patients according to their "MitoScore". Minovia is establishing a novel aspect of cell therapy quality focusing on mitochondrial science, developing robust analytical methods to measure cellular mitochondrial function, as well as modalities to rescue mitochondrial dysfunction in different cell therapies.
Specialties
Where is Minovia Therapeutics located?
Minovia Therapeutics lists 2 office locations.
Compare companies similar to Minovia Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Minovia Therapeutics minoviatx.com | Biotechnology Research | 23 | 2012 | Haifa, Israel |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Minovia Therapeutics
What does Minovia Therapeutics do?
Minovia is a clinical stage company focused on the development and application of mitochondrial cell therapies for patients suffering mitochondrial dysfunction. Mitochondrial Augmentation Technology (MAT) is a cell therapy platform where an off-the-shelf allogeneic isolated mitochondria are developed as cryopreserved, healthy and functional, energy producing organelles and used to augment various cell types to be used as therapeutics products. The lead product, MNV-201 consists of autologous hematopoietic stem and progenitor cells (HSPCs) augmented ex vivo with healthy mitochondria. MNV-201 is currently in clinical trial for Pearson Syndrome and in Pre-clinical stage for Myelodysplastic Syndrome (MDS) indicating encouraging clinical and pre-clinical proof-of-concept for both primary mitochondrial diseases and age-related bone marrow failures. In Minovia we developed novel mitochondria-based biomarkers that allows us to stratify patients according to their "MitoScore". Minovia is establishing a novel aspect of cell therapy quality focusing on mitochondrial science, developing robust analytical methods to measure cellular mitochondrial function, as well as modalities to rescue mitochondrial dysfunction in different cell therapies.
How many employees does Minovia Therapeutics have?
Minovia Therapeutics has around 23 employees on LinkedIn.
Where is Minovia Therapeutics headquartered?
Minovia Therapeutics is headquartered in Haifa, Israel.
Where does Minovia Therapeutics have offices?
Minovia Therapeutics lists 2 office locations, including Haifa, Israel, IL; Woburn, MA, US.
When was Minovia Therapeutics founded?
Minovia Therapeutics was founded in 2012.
Build a lead list from companies like Minovia Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.